tetralin has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Karim, SS; Ali, HF; Anwar, MM; Motaleb, MA; Nael, MA; Syam, YM | 1 |
1 other study(ies) available for tetralin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Rational design and synthesis of new tetralin-sulfonamide derivatives as potent anti-diabetics and DPP-4 inhibitors: 2D & 3D QSAR, in vivo radiolabeling and bio distribution studies.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Male; Molecular Docking Simulation; Quantitative Structure-Activity Relationship; Rats; Sulfonamides; Tetrahydronaphthalenes; Tissue Distribution | 2018 |